| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/15/2002 | WO2002026729A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/15/2002 | WO2002022212A8 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 08/15/2002 | WO2002019961A3 Pharmaceutical compositions for headache, migraine, nausea and emesis |
| 08/15/2002 | WO2002018369A3 Peptidomimetic protease inhibitors |
| 08/15/2002 | WO2002010345A3 Autologous bio-matrix from mammalian liver |
| 08/15/2002 | WO2002000195A3 Methods and compositions for treating pain of the mucous membrane |
| 08/15/2002 | WO2001079246A3 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| 08/15/2002 | WO2001061039A3 5-hydroxytryptamine transporter gene polymorphisms |
| 08/15/2002 | WO2001034168A9 Inhibition of pathogens by bacillus coagulans strains |
| 08/15/2002 | WO2001032877A9 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 08/15/2002 | WO2001027135A9 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/15/2002 | US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/15/2002 | US20020111484 Novel cyclopentene derivatives useful as antagonists of the motilin receptor |
| 08/15/2002 | US20020111481 Generating preferential oligosaccharides derivatives; obtain lactoside, incubate with benzaldehyde dimethylacetal, recover product |
| 08/15/2002 | US20020111378 Inhibitors of IMPDH enzyme |
| 08/15/2002 | US20020111358 Phenoxypropylamine compounds |
| 08/15/2002 | US20020111355 Antitumor agents; contraceptives |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111350 Aryl fused azapolycyclic compounds |
| 08/15/2002 | US20020111334 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| 08/15/2002 | US20020111313 Tripeptide dosage |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020110868 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators |
| 08/15/2002 | US20020110608 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 08/15/2002 | US20020110605 Liver function protecting or improving agent |
| 08/15/2002 | CA2437717A1 G-protein coupled receptors |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437497A1 Lipid-associated molecules |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/15/2002 | CA2437400A1 Aminal diones as potassium channel openers |
| 08/15/2002 | CA2437380A1 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 08/15/2002 | CA2437248A1 Jnk inhibitor |
| 08/15/2002 | CA2437087A1 Methods for the administration of amifostine and related compounds |
| 08/15/2002 | CA2437085A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 08/15/2002 | CA2436741A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | CA2436738A1 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | CA2436470A1 Intracellular signaling molecules |
| 08/15/2002 | CA2436467A1 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles |
| 08/15/2002 | CA2435835A1 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
| 08/15/2002 | CA2435820A1 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 08/15/2002 | CA2435620A1 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 08/15/2002 | CA2433439A1 Proteins and nucleic acids encoding same |
| 08/14/2002 | EP1231219A1 GLucagon-like peptide-2 analogs |
| 08/14/2002 | EP1231212A1 Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders |
| 08/14/2002 | EP1230930A2 Bmp-9 compositions |
| 08/14/2002 | EP1230929A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230342A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 08/14/2002 | EP1230260A1 Hcv ns3 protease inhibitors |
| 08/14/2002 | EP1230244A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 08/14/2002 | EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 08/14/2002 | EP1230241A2 Adenosine receptor antagonists and methods of making and using the same |
| 08/14/2002 | EP1230237A1 Magnesium omeprazole |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2002 | EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1230218A1 Positive modulators of nicotinic receptor agonists |
| 08/14/2002 | EP1230217A1 Positive modulators of nicotinic receptor agonists |
| 08/14/2002 | EP1230216A1 Positive modulators of nicotinic receptor agonists |
| 08/14/2002 | EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229923A1 Inhibition of pathogens by bacillus coagulans strains |
| 08/14/2002 | EP1229918A2 Pharmaceutical composition comprising a combination of metformin and glibenclamide |
| 08/14/2002 | EP1229915A1 Protease inhibitors |
| 08/14/2002 | EP1229914A1 Protease inhibitors |
| 08/14/2002 | EP1229912A1 Protease inhibitors |
| 08/14/2002 | EP1229911A1 Protease inhibitors |
| 08/14/2002 | EP1229802A1 Food product and process for manufacturing same |
| 08/14/2002 | EP1189922A4 Steroid derivatives |
| 08/14/2002 | EP1187591A4 Ibd-associated microbial antigens and methods of using same |
| 08/14/2002 | EP1087961B1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 08/14/2002 | EP1071455A4 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/14/2002 | EP1052967B1 Antiplaque oral composition and method for promoting oral hygiene |
| 08/14/2002 | EP0949899B1 Dentifrice compositions containing polyphosphate and fluoride |
| 08/14/2002 | EP0937076B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | EP0724435B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 08/14/2002 | CN1364166A Polymorphic salt as medicine for migraine |
| 08/14/2002 | CN1364092A Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| 08/14/2002 | CN1364085A Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 08/14/2002 | CN1364083A Transdermal composition of antivomiting agent and preparation containing the same |
| 08/14/2002 | CN1364082A Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having same effective composition |
| 08/14/2002 | CN1364080A Th2 differentiation inhibitors |
| 08/14/2002 | CN1364077A Multilayer pharmaceutical product for release in the colon |
| 08/14/2002 | CN1363392A Process for preparing instant particles for treating hepatitis B |
| 08/14/2002 | CN1363382A Composition for preventing and treating epidemic diarrhea of laying hen |
| 08/14/2002 | CN1363362A Medicine prepared from spearmint for treating chronic and ulcerative colitis and its preparing process |
| 08/14/2002 | CN1363357A Medicine for treating gastrosis |
| 08/14/2002 | CN1363351A Small pill 'Weizhi' |
| 08/14/2002 | CN1363349A Jiabaoyugan San |
| 08/14/2002 | CN1363338A Nano medicine 'Donggui Buxue' and its preparing process |
| 08/14/2002 | CN1363337A Nano medicine 'Compound Dantong' and its preparing process |
| 08/14/2002 | CN1363334A Nano medicine 'Dabuyin' and its preparing process |
| 08/14/2002 | CN1363333A Nano medicine 'Chenxiang Huazhi' and its preparing process |
| 08/14/2002 | CN1363331A Nano storax medicine and its preparing process |